Liu, Z., Wang, D., Li, G., Yi, M., Zhang, Z., Zhong, G., Xu, L., Jiang, R., Zheng, Y., Huang, L., Peng, Y., Liang, L., Li, J., Liu, Y., Lai, J., Lv, X., Xu, Y., Liu, Q., Wang, Z., Liu, Z., Yang, Q., Nie, L., Lei, J., Huang, X., Liu, Z., Jiang, W. (2025). Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial. Nature Communications. https://doi.org/10.1038/s41467-025-59865-1